Canopy Growth (CGC) Change in Acquisitions & Divestments (2019 - 2025)
Canopy Growth's (CGC) quarterly Change in Acquisitions & Divestments came in at -$437422.6 in Q4 2025, down 104.62% year-on-year from $9.5 million in Q4 2024, and up 96.58% quarter-over-quarter from -$12.8 million in Q3 2025.
Canopy Growth (CGC) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Change in Acquisitions & Divestments across 7 years of filings, most recently posting -$437422.6 for Q4 2025.
- Change in Acquisitions & Divestments for Q4 2025 came in at -$437422.6, down 104.62% year-over-year; the trailing twelve-month figure through Dec 2025 was -$13.4 million (up 33.52% YoY), and the FY2025 annual result was -$11.4 million, up 80.36% from the prior year.
- Change in Acquisitions & Divestments came in at -$437422.6 for Q4 2025 at Canopy Growth, up from -$12.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $297.3 million in Q1 2021 to a low of -$274.8 million in Q3 2021.
- The 5-year median for Change in Acquisitions & Divestments is -$10.2 million (2024), against an average of -$29.6 million.
- Across the five-year window, Change in Acquisitions & Divestments soared 487.66% in 2021 and plunged 10676.42% in 2025, its largest moves.
- Canopy Growth's Change in Acquisitions & Divestments stood at -$270.5 million in 2021, then jumped by 44.37% to -$150.5 million in 2022, then surged by 106.21% to $9.3 million in 2023, then advanced by 1.39% to $9.5 million in 2024, then slumped by 104.62% to -$437422.6 in 2025.
- The last three Change in Acquisitions & Divestments figures came in at -$437422.6 (Q4 2025), -$12.8 million (Q3 2025), and -$562214.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -437,422.63 |
| Dec 31, 2025 | -437,422.63 |
| Sep 30, 2025 | -12.80 Mn |
| Sep 30, 2025 | -12.80 Mn |
| Jun 30, 2025 | -562,214.04 |
| Jun 30, 2025 | -562,214.04 |
| Mar 31, 2025 | 363,790.40 |
| Mar 31, 2025 | 363,790.40 |
| Dec 31, 2024 | 9.47 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | -118,754.65 |
| Sep 30, 2024 | -118,754.65 |
| Jun 30, 2024 | -21.95 Mn |
| Jun 30, 2024 | -21.95 Mn |
| Mar 31, 2024 | -7.61 Mn |
| Mar 31, 2024 | -7.61 Mn |
| Dec 31, 2023 | 9.34 Mn |
| Dec 31, 2023 | 9.34 Mn |
| Sep 30, 2023 | -6.61 Mn |
| Sep 30, 2023 | -6.61 Mn |